The potential of psychedelic-assisted therapy
WashU Medicine researchers are helping transform mind-bending psychedelics into treatments for devastating mental illnesses.
Barch honored by national mental health organizations
WashU researcher Deanna Barch was recognized by two national organizations for her work on schizophrenia and other mental health conditions.
Siteman Cancer Center’s new outpatient building named in honor of Gary C. Werths
Siteman Cancer Center’s new building for outpatient care will be named the Gary C. Werths Building. A transformative commitment by the late Werths and his husband, Richard Frimel, will support cancer research and medical student scholarships.
World leaders in ending blood cancer
The Siteman Blood Cancer Center delivers tomorrow’s treatments today.
Mobilizing the best to start the fight earlier
Getting a head start on detection and treatment in adults under 50.
Grant supports resources for the brain imaging community
Adam Eggebrecht, an associate professor of radiology at WashU Medicine, received $4 million from the National Institutes of Health (NIH) to disseminate powerful cloud-based resources to the brain mapping community.
Probiotic delivers anticancer drug to the gut
Researchers at WashU Medicine engineered a yeast probiotic to deliver immunotherapy to the gut where it reduced gastrointestinal tumors in mice, offering a potentially novel strategy to target hard-to-reach gut cancers.
Researchers define new subtypes of common brain disorder
Researchers at WashU have used AI tools to describe three sub-types of Chiari type-1, which will help guide clinicians to make the most effective treatment decisions for their patients.
WashU faculty, alumni lead effort to repair harms caused by systemic racism in St. Louis
Several WashU faculty members contributed to the St. Louis Reparations Commission report, which outlined recommendations for city officials to repair the harm caused by racial injustice.
New drug targets for Alzheimer’s identified from cerebrospinal fluid
Researchers at WashU Medicine have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and progression.
View More Stories